CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
6 results
Search Results
Now showing 1 - 6 of 6
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high‐incidence country(2023) ;Felix Boekstegers ;Dominique Scherer ;Carol Barahona Ponce ;Katherine MarcelainValentina Gárate‐Calderón<jats:title>Abstract</jats:title><jats:p>Since 2006, Chile has been implementing a gallbladder cancer (GBC) prevention program based on prophylactic cholecystectomy for gallstone patients aged 35 to 49 years. The effectiveness of this prevention program has not yet been comprehensively evaluated. We conducted a retrospective study of 473 Chilean GBC patients and 2137 population‐based controls to develop and internally validate three GBC risk prediction models. The Baseline Model accounted for gallstones while adjusting for sex and birth year. Enhanced Model I also included the non‐genetic risk factors: body mass index, educational level, Mapuche surnames, number of children and family history of GBC. Enhanced Model II further included Mapuche ancestry and the genotype for rs17209837. Multiple Cox regression was applied to assess the predictive performance, quantified by the area under the precision‐recall curve (AUC‐PRC) and the number of cholecystectomies needed (NCN) to prevent one case of GBC at age 70 years. The AUC‐PRC for the Baseline Model (0.44%, 95%CI 0.42‐0.46) increased by 0.22 (95%CI 0.15‐0.29) when non‐genetic factors were included, and by 0.25 (95%CI 0.20‐0.30) when incorporating non‐genetic and genetic factors. The overall NCN for Chileans with gallstones (115, 95%CI 104‐131) decreased to 92 (95%CI 60‐128) for Chileans with a higher risk than the median according to Enhanced Model I, and to 80 (95%CI 59‐110) according to Enhanced Model II. In conclusion, age, sex and gallstones are strong risk factors for GBC, but consideration of other non‐genetic factors and individual genotype data improves risk prediction and may optimize allocation of financial resources and surgical capacity.</jats:p>5Scopus© Citations 16 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response(2020) ;Eduardo A. Sagredo ;Alfredo I. Sagredo ;Alejandro Blanco ;Pamela Rojas De SantiagoScopus© Citations 28 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis(2021) ;Pamela R. de Santiago ;Alejandro Blanco ;Fernanda Morales ;Katherine MarcelainOlivier Harismendy2Scopus© Citations 38 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells(2022) ;Fernanda Morales ;Paola Pérez ;Julio C. Tapia ;Lorena Lobos-GonzálezJosé Manuel Herranz2Scopus© Citations 12 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ski Is Required for Tri-Methylation of H3K9 in Major Satellite and for Repression of Pericentromeric Genes: Mmp3, Mmp10 and Mmp13, in Mouse Fibroblasts(2020) ;Claudio Cappelli ;Hugo Sepulveda; ;Víctor PolaUlises UrzúaScopus© Citations 2 5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Concordance Analysis of ALK Gene Fusion Detection Methods in Patients with Non–Small-Cell Lung Cancer from Chile, Brazil, and Peru(2021) ;Gonzalo Sepúlveda-Hermosilla ;Matías Freire ;Alejandro Blanco ;Javier CáceresRodrigo Lizana1Scopus© Citations 6